At Akron, we manufacture high-quality compliant cGMP plasmid DNA for pre-clinical, clinical, and commercial gene therapy and vaccine companies.
Akron offers comprehensive recombinant protein and nuclease development and manufacturing under cGMP compliance. Our approach to developing novel cytokines and gene editing tools is to establish a strong foundation through extensive investigation and optimization, enabling a seamless transition to large-scale production.
Capitalizing on our established platform for manufacturing cGMP-compliant, clinical-grade ancillary products, Akron is well-positioned to provide custom development and manufacturing to accelerate the commercialization of advanced therapies.
We offer cGMP-compliant viral transduction enhancers and non-viral transfection reagents and solutions to enable your therapeutic programs’ success. We offer flexible filling capabilities and several manufacturing environments to meet your needs.
Akron’s high-quality cGMP Recombinant Proteins offer the consistency, safety, and efficacy that empower today’s leading clinical and commercial cell therapy companies.
Akron’s proven blood products deliver safety and performance backed by robust and redundant supply. Because you can’t afford to compromise.
We offer critical media and media supplements in both cGMP and high-quality research grade.
Our CSS product line is available in single-use, ready-to-use bags with weldable tubing to ensure consistency and sterility. This product line was developed to integrate optimally dosed, cGMP-compliant blood-derived products and liquid cytokines across manufacturing platforms.
Oct 28, 2022
Meeting the Increasing Manufacturing Demands of the Rapidly Growing Cell and Gene Therapy and Vaccine Markets, Upcoming Webinar Hosted by Xtalks
Members of the Akron Bio team are heading to Boston for the mRNA Process Development and Manufacturing Summit. Connect with us to learn how we can support your plasmid development and manufacturing needs.
Join the Akron Bio team in Boston for the iPSC Derived Cell Therapies Summit from October 3 - 4. We hope to see you there!
Akron Bio is proud to be a Gold Level Sponsor at this year's Cell & Gene Meeting on the Mesa. Stop by our exhibit or connect with one of our team members to learn more about our products, services, and solutions.
Akron Bio’s Founder and Board Member, Claudia Zylberberg will be co-chairing an upcoming workshop from NASEM Health and Medicine Division Forum on Regenerative Medicine. Join her on October 17th to learn more about the challenges & opportunities in manufacturing Regenerative Medicine therapeutics to improve the delivery of treatments to patients.
Akron Bio will be attending the Innate Killer Summit in London, England. We hope to see you there!
Connect with our team in Brussels at this year's European Society of Gene & Cell Therapy Annual Congress and learn more about our products and service offerings!